Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Olympus Corp (OLYMY)

Olympus Corp (OLYMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.8800 +4.44%
on 11/04/24
19.6900 -10.46%
on 10/10/24
-1.2500 (-6.62%)
since 10/04/24
3-Month
15.4500 +14.11%
on 08/05/24
19.6900 -10.46%
on 10/10/24
+1.6700 (+10.46%)
since 08/02/24
52-Week
13.1300 +34.27%
on 02/14/24
19.6900 -10.46%
on 10/10/24
+3.6300 (+25.93%)
since 11/03/23

Most Recent Stories

More News
Olympus Launches VISERA S, a New Imaging Platform

Olympus Launches VISERA S, a New Imaging Platform

OLYMY : 17.6300 (+0.40%)
OCPNF : 17.1436 (+2.59%)
Olympus Launches New 4K Camera Head for Urological Endoscopy

Olympus Launches New 4K Camera Head for Urological Endoscopy

SONY : 17.74 (+0.06%)
OLYMY : 17.6300 (+0.40%)
OCPNF : 17.1436 (+2.59%)
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India

Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India

OCPNF : 17.1436 (+2.59%)
OLYMY : 17.6300 (+0.40%)
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System

NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System

NPPXF : 0.9648 (-2.63%)
NTTYY : 24.2200 (+0.50%)
OCPNY : 18.0000 (-1.37%)
OCPNF : 17.1436 (+2.59%)
OLYMY : 17.6300 (+0.40%)
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd

OCPNY : 18.0000 (-1.37%)
OCPNF : 17.1436 (+2.59%)
OLYMY : 17.6300 (+0.40%)
Olympus Names Dr. John de Csepel as Chief Medical Officer

Olympus Names Dr. John de Csepel as Chief Medical Officer

OCPNY : 18.0000 (-1.37%)
OCPNF : 17.1436 (+2.59%)
OLYMY : 17.6300 (+0.40%)
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases

Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases

OCPNY : 18.0000 (-1.37%)
OCPNF : 17.1436 (+2.59%)
OLYMY : 17.6300 (+0.40%)
Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision

Olympus Announces Plan to Establish Digital Excellence Centers Following Acquisition of Cloud-AI Endoscopy Startup Odin Vision

OCPNY : 18.0000 (-1.37%)
OCPNF : 17.1436 (+2.59%)
OLYMY : 17.6300 (+0.40%)
Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer

Olympus Names Wenlei Yang the Newly Established Chief Diversity, Equity and Inclusion Officer

OCPNY : 18.0000 (-1.37%)
OCPNF : 17.1436 (+2.59%)
OLYMY : 17.6300 (+0.40%)

Key Turning Points

3rd Resistance Point 18.9467
2nd Resistance Point 18.3833
1st Resistance Point 18.0067
Last Price 17.6300
1st Support Level 17.0667
2nd Support Level 16.5033
3rd Support Level 16.1267

See More

52-Week High 19.6900
Last Price 17.6300
Fibonacci 61.8% 17.1841
Fibonacci 50% 16.4100
Fibonacci 38.2% 15.6359
52-Week Low 13.1300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar